DTC Genomics Firms Respond to Range of Concerns at Fed-Sponsored Roundtable | GenomeWeb
This article has been updated from a previous version to clarify Esther Dyson's comments.
WASHINGTON, DC (GenomeWeb News) – A panel discussion hosted by the Department of Health and Human Services here yesterday served as a forum for several direct-to-consumer genomic testing firms to address a growing number of scientific, ethical, and regulatory questions surrounding their business models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.